{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:13:22Z","timestamp":1761513202021,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.3816\/cbc.2009.n.011","type":"journal-article","created":{"date-parts":[[2009,3,19]],"date-time":"2009-03-19T21:12:05Z","timestamp":1237497125000},"page":"56-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Rational and Successful Use of Carboplatin and Albumin-Bound Paclitaxel in a Patient with Recurrent Metaplastic Carcinoma Who Presented with Multi-Organ Tumor Emboli"],"prefix":"10.3816","volume":"9","author":[{"given":"Rita S.","family":"Mehta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toni","family":"Schubbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip M.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2009.n.011_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/1097-0142(19870701)60:1<90::AID-CNCR2820600116>3.0.CO;2-C","article-title":"Cerebral infarction as a result of tumor emboli","volume":"60","author":"O'Neill","year":"1987","journal-title":"Cancer"},{"key":"10.3816\/CBC.2009.n.011_bib2","first-page":"108","article-title":"Systemic tumor emboli from primary bronchogenic carcinoma","volume":"42","author":"Misawa","year":"1989","journal-title":"Kyobu Geka"},{"key":"10.3816\/CBC.2009.n.011_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0899-7071(02)00445-X","article-title":"Metastatic chondrosarcoma to the lung with extension into the left atrium via invasion of the pulmonary veins: presentation as embolic cerebral infarction","volume":"26","author":"Woodring","year":"2002","journal-title":"Clin Imaging"},{"key":"10.3816\/CBC.2009.n.011_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/PAS.0b013e3181592201","article-title":"Laminin 5. Expression in metaplastic breast carcinomas","volume":"32","author":"Carpenter","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.3816\/CBC.2009.n.011_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1008329910362","article-title":"Metaplastic breast cancer: prognosis and response to systemic therapy","volume":"10","author":"Rayson","year":"1999","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2009.n.011_bib6","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1080\/02841860500513235","article-title":"Metaplastic carcinoma of the breast. Clinical presentation, treatment results and prognostic factors","volume":"45","author":"Al Sayed","year":"2006","journal-title":"Acta Oncol (Madr)"},{"key":"10.3816\/CBC.2009.n.011_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1245\/s10434-006-9124-7","article-title":"Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Database","volume":"14","author":"Pezzi","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.3816\/CBC.2009.n.011_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/nrc1457","article-title":"Hallmarks of \u2018BRCAness\u2019 in sporadic cancers","volume":"4","author":"Turner","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.3816\/CBC.2009.n.011_bib9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/sj.bjc.6600859","article-title":"BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells","volume":"88","author":"Tassone","year":"2003","journal-title":"Br J Cancer"},{"key":"10.3816\/CBC.2009.n.011_bib11","doi-asserted-by":"crossref","first-page":"7794","DOI":"10.1200\/JCO.2005.04.937","article-title":"Superior efficacy of albuminbound paclitaxel, ABI-007, compared with polyethylated castor oil-based paclitaxel in women with metastatic breast cancer: results of a phase III trial","volume":"23","author":"Gradishar","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.011_bib12","unstructured":"Desai N, Yao Z, Trieu V, et al. Evidence of greater antitumor activity of Cremophor-free nanoparticle albumin-bound (nab) paclitaxel (Abraxane) compared to Taxol: role of a novel albumin transporter mechanism. Presented at: the 26th Annual San Antonio Breast Cancer Symposium; December 3-6, 2003; San Antonio, TX."},{"key":"10.3816\/CBC.2009.n.011_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10549-006-9184-1","article-title":"Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer","volume":"99","author":"Pinilla","year":"2006","journal-title":"Breast Cancer Res Treat"},{"key":"10.3816\/CBC.2009.n.011_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1078-0432.CCR-06-1371","article-title":"Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis","volume":"13","author":"Savage","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2009.n.011_bib15","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1200\/JCO.2006.10.0883","article-title":"Potential chemotherapy options in the triple negative subtype of breast cancer","volume":"25","author":"Altundag","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2009.n.011_bib16","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox. Primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Carey","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CBC.2009.n.011_bib17","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1056\/NEJMoa072113","article-title":"Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer","volume":"357","author":"Miller","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911706450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:09:34Z","timestamp":1761512974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911706450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S1526820911706450"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2009.n.011","relation":{},"ISSN":["1526-8209"],"issn-type":[{"type":"print","value":"1526-8209"}],"subject":[],"published":{"date-parts":[[2009,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rational and Successful Use of Carboplatin and Albumin-Bound Paclitaxel in a Patient with Recurrent Metaplastic Carcinoma Who Presented with Multi-Organ Tumor Emboli","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2009.n.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}